ACTRN12613000065796招募中未知
Anti-fibrotic role of eplerenone on diffuse myocardial fibrosis and diastolic function in patients with hypertrophic cardiomyopathy
Dr Andrew Taylor0 个研究点目标入组 80 人开始时间: 2013年1月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Confirmed diagnosis of hypertrophic cardiomyopathy
- •Ability to swallow pills
- •Not pregnant
排除标准
- •Contra-indication to cardiac MRI, including administration of gadolinium-based IV contrast
- •Co-existing cardiac condition with may contribute to myocardial fibrosis
- •Unable to take aldosterone antagonist
研究者
相似试验
终止
4 期
The Effects of Eplerenone on Markers of Myocardial Fibrosis in Adult Congenital Heart DiseaseTetralogy of FallotTransposition of the Great Vessels With an Arterial SwitchSingle Ventricle With a Fontan PalliationNCT01971593Washington University School of Medicine26
尚未招募
不适用
Effects of eplerenone on cardiovascular and metabolic disorders in patients with primary aldosteronismessential hypertension, primary aldosteronismJPRN-UMIN000004581Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University100
尚未招募
不适用
A new drug Pirfenidone used in relieving the stiffness of the mouth caused by tobacco chewingCTRI/2020/03/023844Dr Akshaya S R
招募中
1 期
Evaluation of the effect of Eplerenone in Central serous chorioretinopathy )CSCRCentral serous chorioretinopathyIRCT20220122053792N1Oroumia University of Medical Sciences34
尚未招募
4 期
Heart Transplant Myocardial Fibrosis StudyDiastolic dysfunctionMyocardial fibrosis after heart transplantationCardiovascular - Other cardiovascular diseasesACTRN12606000193572The Alfred Hospital40